{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T10:27:15Z","timestamp":1786789635186,"version":"build-2736575974"},"reference-count":130,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012681","name":"Universit\u00e4tsklinikum K\u00f6ln","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012681","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The Infectious Diseases Working Party (AGIHO) was established in 1996 as one of the subgroups of the German Society of Hematology and Medical Oncology (DGHO). Marking its 30th anniversary this year, the AGIHO reflects on a period of significant achievement and growth. Beyond its core mission of developing evidence-based clinical practice guidelines for the prevention, diagnosis, and management of infections in patients with cancer, the AGIHO has evolved into a vital platform for clinical trials, collaborative research, and postgraduate medical education. To ensure long-term sustainability and foster emerging talent, \u201cYoung AGIHO\u201d was launched in 2023. This initiative aims to strengthen networking among early career physicians specializing in hematology and oncology with a strong focus on infectious diseases. The working party has also expanded its geographical footprint by integrating colleagues from Austria and Switzerland, thereby enhancing its international presence. Through the publication of guidelines in high-ranking international journals, AGIHO visibility has increased significantly. Representatives of the working party now serve as experts for scientific and health policy committees both nationally and internationally. As one of the DGHO's largest and most active subgroups, the AGIHO is ideally positioned to address future challenges in the field.<\/jats:p>","DOI":"10.1007\/s00277-026-07194-8","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:47:48Z","timestamp":1785768468000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["30 years in service, 1996\u20132026: Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)"],"prefix":"10.1007","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9599-3137","authenticated-orcid":false,"given":"Oliver A.","family":"Cornely","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2378-2466","authenticated-orcid":false,"given":"Georg","family":"Maschmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Hiddemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0935-7813","authenticated-orcid":false,"given":"Nico","family":"Bekaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9615-2564","authenticated-orcid":false,"given":"Nicola","family":"Giesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2946-7785","authenticated-orcid":false,"given":"Cornelia","family":"Lass-Fl\u00f6rl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3928-2503","authenticated-orcid":false,"given":"Sibylle C.","family":"Mellinghoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9205-1440","authenticated-orcid":false,"given":"Verena","family":"Petzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6766-8297","authenticated-orcid":false,"given":"Jon","family":"Salmanton-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8845-6656","authenticated-orcid":false,"given":"Michael","family":"Sandherr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1892-5098","authenticated-orcid":false,"given":"Enrico","family":"Schalk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xaver","family":"Schiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3071-6945","authenticated-orcid":false,"given":"Martin","family":"Schmidt-Hieber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4388-3117","authenticated-orcid":false,"given":"Danila","family":"Seidel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9152-2469","authenticated-orcid":false,"given":"Jannik","family":"Stemler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7351-8060","authenticated-orcid":false,"given":"Daniel","family":"Teschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7048-6590","authenticated-orcid":false,"given":"Laura N.","family":"Walti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4334-3403","authenticated-orcid":false,"given":"Christina T.","family":"Rieger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"issue":"4","key":"7194_CR1","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1200\/JCO.2009.25.8616","volume":"28","author":"CA Schiffer","year":"2010","unstructured":"Schiffer CA (2010) I am older, not elderly, said the patient with acute myeloid leukemia. J Clin Oncol 28(4):521\u2013523","journal-title":"J Clin Oncol"},{"issue":"11","key":"7194_CR2","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1007\/s00210-021-02144-9","volume":"394","author":"R Seifert","year":"2021","unstructured":"Seifert R, Schirmer B (2021) Problems associated with the use of the term antibiotics. Naunyn Schmiedebergs Arch Pharmacol 394(11):2153\u20132166","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"8","key":"7194_CR3","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1093\/jac\/dkae199","volume":"79","author":"R Lee","year":"2024","unstructured":"Lee R, Nho D, Cho SY, Park S, Cho BS, Kim HJ et al (2024) Impact of an antimicrobial stewardship programme on antibiotic utilization and resistance burden in patients with acute leukaemia: an 11-year longitudinal cohort study using interrupted time-series analysis. J Antimicrob Chemother 79(8):1998\u20132007","journal-title":"J Antimicrob Chemother"},{"key":"7194_CR4","unstructured":"Cancer Patients Europe (2026) Combating AMR in Oncology: A Strategic Imperative for EU Health Policy. Retrieved on March 18, 2026 from https:\/\/cancerpatientseurope.org\/wp-content\/uploads\/2026\/03\/CPE-AMR-and-Cancer-White-Paper.pdf"},{"key":"7194_CR5","unstructured":"AGIHO Guidelines (Leitlinien) [Available from: https:\/\/www.dgho.de\/arbeitskreise\/a-g\/agiho"},{"key":"7194_CR6","unstructured":"Onkopedia [Available from: https:\/\/www.onkopedia.com\/de"},{"issue":"4","key":"7194_CR7","doi-asserted-by":"publisher","first-page":"e195","DOI":"10.1016\/S1470-2045(25)00765-X","volume":"27","author":"SC Mellinghoff","year":"2026","unstructured":"Mellinghoff SC, Liss B, Stemler J, Petzer V, Egger-Heidrich K, Monin MB et al (2026) Anti-infective vaccination strategies in patients with haematological malignancies or solid tumours: updated guideline of the Infectious Diseases Working Party of the German Society for Hematology and Medical Oncology. Lancet Oncol 27(4):e195\u2013e206","journal-title":"Lancet Oncol"},{"key":"7194_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2026.116244","volume":"235","author":"M Sandherr","year":"2026","unstructured":"Sandherr M, Schalk E, Heinz WJ, K\u00f6hler P, Krause SW, Liss B et al (2026) Evidence-based AGIHO guideline update on prophylaxis of infectious complications with granulocyte-stimulating factors (G-CSF) for the treatment of adult patients with cancer. Eur J Cancer 235:116244","journal-title":"Eur J Cancer"},{"issue":"2","key":"7194_CR9","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s00277-026-06769-9","volume":"105","author":"N Giesen","year":"2026","unstructured":"Giesen N, Mellinghoff SC, Khatamzas E, Korell F, Hentrich M, Einsele H et al (2026) Prevention, diagnosis and management of community acquired respiratory virus infections including COVID-19 in patients with cancer: 2025 updated evidence-based guideline of the infectious diseases working party (AGIHO) of the German society for hematology and medical oncology (DGHO). Ann Hematol 105(2):46","journal-title":"Ann Hematol"},{"key":"7194_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2025.116103","volume":"232","author":"R Akdas","year":"2024","unstructured":"Akdas R, Schalk E, Stemler J, Schwartz S, Meyding-Lamad\u00e9 U, Panse JP et al (2024) CNS infections in patients with hematological or oncological diseases (including cellular therapies)\u2009\u2212\u20092024 update of the guideline of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Eur J Cancer 232:116103","journal-title":"Eur J Cancer"},{"key":"7194_CR11","doi-asserted-by":"publisher","first-page":"101214","DOI":"10.1016\/j.lanepe.2025.101214","volume":"51","author":"M Sandherr","year":"2025","unstructured":"Sandherr M, Stemler J, Schalk E, Hattenhauer T, Hentrich M, Hertenstein B et al (2025) 2024 update of the AGIHO guideline on diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients with solid tumours and hematological malignancies. Lancet Reg Health Eur 51:101214","journal-title":"Lancet Reg Health Eur"},{"issue":"8","key":"7194_CR12","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1093\/jac\/dkad143","volume":"78","author":"J Stemler","year":"2023","unstructured":"Stemler J, Mellinghoff SC, Khodamoradi Y, Sprute R, Classen AY, Zapke SE et al (2023) Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO). J Antimicrob Chemother 78(8):1813\u20131826","journal-title":"J Antimicrob Chemother"},{"key":"7194_CR13","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ejca.2022.11.030","volume":"181","author":"N Giesen","year":"2022","unstructured":"Giesen N, Busch E, Schalk E, Beutel G, R\u00fcthrich MM, Hentrich M et al (2022) AGIHO guideline on evidence-based management of COVID-19 in cancer patients: 2022 update on vaccination, pharmacological prophylaxis and therapy in light of the omicron variants. Eur J Cancer 181:102\u201318","journal-title":"Eur J Cancer"},{"issue":"3","key":"7194_CR14","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s00277-021-04746-y","volume":"101","author":"L Henze","year":"2022","unstructured":"Henze L, Buhl C, Sandherr M, Cornely OA, Heinz WJ, Khodamoradi Y et al (2022) Management of herpesvirus reactivations in patients with solid tumours and hematologic malignancies: update of the guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO) on herpes simplex virus type 1, herpes simplex virus type 2, and varicella zoster virus. Ann Hematol 101(3):491\u2013511","journal-title":"Ann Hematol"},{"issue":"6","key":"7194_CR15","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1007\/s00277-021-04452-9","volume":"100","author":"AY Classen","year":"2020","unstructured":"Classen AY, Henze L, von Lilienfeld-Toal M, Maschmeyer G, Sandherr M, Graeff LD et al (2020) Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematologic malignancies and solid tumors: 2020 updated guidelines of the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO\/DGHO). Ann Hematol 100(6):1603\u201320","journal-title":"Ann Hematol"},{"key":"7194_CR16","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ejca.2021.01.033","volume":"147","author":"N Giesen","year":"2021","unstructured":"Giesen N, Sprute R, R\u00fcthrich M, Khodamoradi Y, Mellinghoff SC, Beutel G et al (2021) 2021 update of the AGIHO guideline on evidence-based management of COVID-19 in patients with cancer regarding diagnostics, viral shedding, vaccination and therapy. Eur J Cancer 147:154\u2013160","journal-title":"Eur J Cancer"},{"issue":"2","key":"7194_CR17","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00277-020-04297-8","volume":"100","author":"M Christopeit","year":"2020","unstructured":"Christopeit M, Schmidt-Hieber M, Sprute R, Buchheidt D, Hentrich M, Karthaus M et al (2020) Prophylaxis, diagnosis and therapy of infections in patients undergoing high-dose chemotherapy and autologous haematopoietic stem cell transplantation. 2020 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Hematol 100(2):321\u201336","journal-title":"Ann Hematol"},{"issue":"1","key":"7194_CR18","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00277-020-04286-x","volume":"100","author":"B B\u00f6ll","year":"2020","unstructured":"B\u00f6ll B, Schalk E, Buchheidt D, Hasenkamp J, Kiehl M, Kiderlen TR et al (2020) Central venous catheter-related infections in hematology and oncology: 2020 updated guidelines on diagnosis, management, and prevention by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Hematol 100(1):239\u201359","journal-title":"Ann Hematol"},{"key":"7194_CR19","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ejca.2020.09.009","volume":"140","author":"N Giesen","year":"2020","unstructured":"Giesen N, Sprute R, R\u00fcthrich M, Khodamoradi Y, Mellinghoff SC, Beutel G et al (2020) Evidence-based management of COVID-19 in cancer patients: guideline by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO). Eur J Cancer 140:86\u2013104","journal-title":"Eur J Cancer"},{"issue":"7","key":"7194_CR20","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/myc.13082","volume":"63","author":"M Ruhnke","year":"2019","unstructured":"Ruhnke M, Cornely OA, Schmidt-Hieber M, Alakel N, Boell B, Buchheidt D et al (2019) Treatment of invasive fungal diseases in cancer patients-revised 2019 recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Mycoses 63(7):653\u201382","journal-title":"Mycoses"},{"issue":"5","key":"7194_CR21","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1007\/s00277-019-03622-0","volume":"98","author":"M Kochanek","year":"2018","unstructured":"Kochanek M, Schalk E, von Bergwelt-Baildon M, Beutel G, Buchheidt D, Hentrich M et al (2018) Management of sepsis in neutropenic cancer patients: 2018 guidelines from the Infectious Diseases Working Party (AGIHO) and Intensive Care Working Party (iCHOP) of the German Society of Hematology and Medical Oncology (DGHO). Ann Hematol 98(5):1051\u201369","journal-title":"Ann Hematol"},{"issue":"11","key":"7194_CR22","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1111\/myc.12838","volume":"61","author":"M Ruhnke","year":"2018","unstructured":"Ruhnke M, Behre G, Buchheidt D, Christopeit M, Hamprecht A, Heinz W et al (2018) Diagnosis of invasive fungal diseases in haematology and oncology: 2018 update of the recommendations of the infectious diseases working party of the German society for hematology and medical oncology (AGIHO). Mycoses 61(11):796\u2013813","journal-title":"Mycoses"},{"issue":"6","key":"7194_CR23","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1093\/annonc\/mdy117","volume":"29","author":"CT Rieger","year":"2018","unstructured":"Rieger CT, Liss B, Mellinghoff S, Buchheidt D, Cornely OA, Egerer G et al (2018) Anti-infective vaccination strategies in patients with hematologic malignancies or solid tumors-Guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO). Ann Oncol 29(6):1354\u20131365","journal-title":"Ann Oncol"},{"issue":"2","key":"7194_CR24","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00277-017-3196-2","volume":"97","author":"SC Mellinghoff","year":"2018","unstructured":"Mellinghoff SC, Panse J, Alakel N, Behre G, Buchheidt D, Christopeit M et al (2018) Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO). Ann Hematol 97(2):197\u2013207","journal-title":"Ann Hematol"},{"issue":"1","key":"7194_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00277-017-3183-7","volume":"97","author":"M Schmidt-Hieber","year":"2018","unstructured":"Schmidt-Hieber M, Bierwirth J, Buchheidt D, Cornely OA, Hentrich M, Maschmeyer G et al (2018) Diagnosis and management of gastrointestinal complications in adult cancer patients: 2017 updated evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Hematol 97(1):31\u201349","journal-title":"Ann Hematol"},{"issue":"11","key":"7194_CR26","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1007\/s00277-017-3098-3","volume":"96","author":"WJ Heinz","year":"2017","unstructured":"Heinz WJ, Buchheidt D, Christopeit M, von Lilienfeld-Toal M, Cornely OA, Einsele H et al (2017) Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Hematol 96(11):1775\u201392","journal-title":"Ann Hematol"},{"issue":"7","key":"7194_CR27","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1093\/annonc\/mdw155","volume":"27","author":"M Schmidt-Hieber","year":"2016","unstructured":"Schmidt-Hieber M, Silling G, Schalk E, Heinz W, Panse J, Penack O et al (2016) CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)-Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Oncol 27(7):1207\u20131225","journal-title":"Ann Oncol"},{"issue":"9","key":"7194_CR28","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1007\/s00277-015-2447-3","volume":"94","author":"M Sandherr","year":"2015","unstructured":"Sandherr M, Hentrich M, von Lilienfeld-Toal M, Massenkeil G, Neumann S, Penack O et al (2015) Antiviral prophylaxis in patients with solid tumours and haematological malignancies\u2013update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO). Ann Hematol 94(9):1441\u201350","journal-title":"Ann Hematol"},{"issue":"1","key":"7194_CR29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/annonc\/mdu192","volume":"26","author":"G Maschmeyer","year":"2015","unstructured":"Maschmeyer G, Carratal\u00e0 J, Buchheidt D, Hamprecht A, Heussel CP, Kahl C et al (2015) Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Oncol 26(1):21\u201333","journal-title":"Ann Oncol"},{"issue":"7","key":"7194_CR30","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1007\/s00277-014-2086-0","volume":"93","author":"O Penack","year":"2014","unstructured":"Penack O, Becker C, Buchheidt D, Christopeit M, Kiehl M, von Lilienfeld-Toal M et al (2014) Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO). Ann Hematol 93(7):1083\u201395","journal-title":"Ann Hematol"},{"issue":"9","key":"7194_CR31","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1093\/annonc\/mdu035","volume":"25","author":"JJ Vehreschild","year":"2014","unstructured":"Vehreschild JJ, B\u00f6hme A, Cornely OA, Kahl C, Karthaus M, Kreuzer KA et al (2014) Prophylaxis of infectious complications with colony-stimulating factors in adult cancer patients undergoing chemotherapy-evidence-based guidelines from the Infectious Diseases Working Party AGIHO of the German Society for Haematology and Medical Oncology (DGHO). Ann Oncol 25(9):1709\u20131718","journal-title":"Ann Oncol"},{"issue":"1","key":"7194_CR32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00277-013-1867-1","volume":"93","author":"S Mousset","year":"2014","unstructured":"Mousset S, Buchheidt D, Heinz W, Ruhnke M, Cornely OA, Egerer G et al (2014) Treatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 93(1):13\u201332","journal-title":"Ann Hematol"},{"issue":"4","key":"7194_CR33","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00277-013-1698-0","volume":"92","author":"S Neumann","year":"2013","unstructured":"Neumann S, Krause SW, Maschmeyer G, Schiel X, von Lilienfeld-Toal M (2013) Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 92(4):433\u2013442","journal-title":"Ann Hematol"},{"issue":"5","key":"7194_CR34","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1093\/annonc\/mdt001","volume":"24","author":"MJ Vehreschild","year":"2013","unstructured":"Vehreschild MJ, Vehreschild JJ, H\u00fcbel K, Hentrich M, Schmidt-Hieber M, Christopeit M et al (2013) Diagnosis and management of gastrointestinal complications in adult cancer patients: evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Oncol 24(5):1189\u20131202","journal-title":"Ann Oncol"},{"issue":"8","key":"7194_CR35","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1007\/s00277-012-1456-8","volume":"91","author":"F Weissinger","year":"2012","unstructured":"Weissinger F, Auner HW, Bertz H, Buchheidt D, Cornely OA, Egerer G et al (2012) Antimicrobial therapy of febrile complications after high-dose chemotherapy and autologous hematopoietic stem cell transplantation\u2013guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 91(8):1161\u201374","journal-title":"Ann Hematol"},{"issue":"4","key":"7194_CR36","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1093\/annonc\/mdr407","volume":"23","author":"M Ruhnke","year":"2012","unstructured":"Ruhnke M, B\u00f6hme A, Buchheidt D, Cornely O, Donhuijsen K, Einsele H et al (2012) Diagnosis of invasive fungal infections in hematology and oncology\u2013guidelines from the Infectious Diseases Working Party in Haematology and Oncology of the German Society for Haematology and Oncology (AGIHO). Ann Oncol 23(4):823\u201333","journal-title":"Ann Oncol"},{"issue":"2","key":"7194_CR37","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00277-008-0622-5","volume":"88","author":"A B\u00f6hme","year":"2009","unstructured":"B\u00f6hme A, Ruhnke M, Buchheidt D, Cornely OA, Einsele H, Enzensberger R et al (2009) Treatment of invasive fungal infections in cancer patients\u2013recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 88(2):97\u2013110","journal-title":"Ann Hematol"},{"issue":"1","key":"7194_CR38","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3324\/haematol.2022.280847","volume":"108","author":"F Marchesi","year":"2023","unstructured":"Marchesi F, Salmanton-Garc\u00eda J, Emarah Z, Piukovics K, Nucci M, L\u00f3pez-Garc\u00eda A et al (2023) COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA). Haematologica 108(1):22\u201333","journal-title":"Haematologica"},{"issue":"7","key":"7194_CR39","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/s00277-006-0096-2","volume":"85","author":"O Penack","year":"2006","unstructured":"Penack O, Beinert T, Buchheidt D, Einsele H, Hebart H, Kiehl MG et al (2006) Management of sepsis in neutropenia: guidelines of the infectious diseases working party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 85(7):424\u2013433","journal-title":"Ann Hematol"},{"issue":"7","key":"7194_CR40","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1093\/annonc\/mdj132","volume":"17","author":"M Sandherr","year":"2006","unstructured":"Sandherr M, Einsele H, Hebart H, Kahl C, Kern W, Kiehl M et al (2006) Antiviral prophylaxis in patients with haematological malignancies and solid tumours: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Oncology (DGHO). Ann Oncol 17(7):1051\u20131059","journal-title":"Ann Oncol"},{"issue":"8","key":"7194_CR41","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1093\/annonc\/mdi238","volume":"16","author":"WH Kr\u00fcger","year":"2005","unstructured":"Kr\u00fcger WH, Bohlius J, Cornely OA, Einsele H, Hebart H, Massenkeil G et al (2005) Antimicrobial prophylaxis in allogeneic bone marrow transplantation. Guidelines of the infectious diseases working party (AGIHO) of the german society of haematology and oncology. Ann Oncol 16(8):1381\u20131390","journal-title":"Ann Oncol"},{"issue":"Suppl 2","key":"7194_CR42","doi-asserted-by":"publisher","first-page":"S105","DOI":"10.1007\/s00277-003-0764-4","volume":"82","author":"H Link","year":"2003","unstructured":"Link H, B\u00f6hme A, Cornely OA, H\u00f6ffken K, Kellner O, Kern WV et al (2003) Antimicrobial therapy of unexplained fever in neutropenic patients\u2013guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschaft Supportivmassnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG-German Cancer Society). Ann Hematol 82(Suppl 2):S105\u2013S117","journal-title":"Ann Hematol"},{"issue":"Suppl 2","key":"7194_CR43","doi-asserted-by":"publisher","first-page":"S118","DOI":"10.1007\/s00277-003-0765-3","volume":"82","author":"G Maschmeyer","year":"2003","unstructured":"Maschmeyer G, Beinert T, Buchheidt D, Einsele H, Heussel CP, Kiehl M et al (2003) Diagnosis and antimicrobial therapy of pulmonary infiltrates in febrile neutropenic patients\u2013guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 82(Suppl 2):S118\u2013S126","journal-title":"Ann Hematol"},{"issue":"Suppl 2","key":"7194_CR44","doi-asserted-by":"publisher","first-page":"S127","DOI":"10.1007\/s00277-003-0766-2","volume":"82","author":"D Buchheidt","year":"2003","unstructured":"Buchheidt D, B\u00f6hme A, Cornely OA, F\u00e4tkenheuer G, Fuhr HG, Heussel G et al (2003) Diagnosis and treatment of documented infections in neutropenic patients\u2013recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 82(Suppl 2):S127\u2013S132","journal-title":"Ann Hematol"},{"issue":"Suppl 2","key":"7194_CR45","doi-asserted-by":"publisher","first-page":"S133","DOI":"10.1007\/s00277-003-0767-1","volume":"82","author":"A B\u00f6hme","year":"2003","unstructured":"B\u00f6hme A, Ruhnke M, Buchheidt D, Karthaus M, Einsele H, Guth S et al (2003) Treatment of fungal infections in hematology and oncology\u2013guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 82(Suppl 2):S133-40","journal-title":"Ann Hematol"},{"issue":"Suppl 2","key":"7194_CR46","doi-asserted-by":"publisher","first-page":"S141","DOI":"10.1007\/s00277-003-0768-0","volume":"82","author":"M Ruhnke","year":"2003","unstructured":"Ruhnke M, B\u00f6hme A, Buchheidt D, Donhuijsen K, Einsele H, Enzensberger R et al (2003) Diagnosis of invasive fungal infections in hematology and oncology\u2013guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 82(Suppl 2):S141\u2013S148","journal-title":"Ann Hematol"},{"issue":"Suppl 2","key":"7194_CR47","doi-asserted-by":"publisher","first-page":"S149","DOI":"10.1007\/s00277-003-0769-z","volume":"82","author":"G F\u00e4tkenheuer","year":"2003","unstructured":"F\u00e4tkenheuer G, Buchheidt D, Cornely OA, Fuhr HG, Karthaus M, Kisro J et al (2003) Central venous catheter (CVC)-related infections in neutropenic patients\u2013guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 82(Suppl 2):S149\u2013S157","journal-title":"Ann Hematol"},{"issue":"Suppl 2","key":"7194_CR48","doi-asserted-by":"publisher","first-page":"S158","DOI":"10.1007\/s00277-003-0770-6","volume":"82","author":"X Schiel","year":"2003","unstructured":"Schiel X, Hebart H, Kern WV, Kiehl MG, S\u00f6lch JP, Wilhelm S et al (2003) Sepsis in neutropenia\u2013guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 82(Suppl 2):S158\u2013S166","journal-title":"Ann Hematol"},{"issue":"Suppl 2","key":"7194_CR49","doi-asserted-by":"publisher","first-page":"S167","DOI":"10.1007\/s00277-003-0771-5","volume":"82","author":"H Bertz","year":"2003","unstructured":"Bertz H, Auner HW, Weissinger F, Salwender HJ, Einsele H, Egerer G et al (2003) Antimicrobial therapy of febrile complications after high-dose chemo-\/radiotherapy and autologous hematopoietic stem cell transplantation\u2013guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 82(Suppl 2):S167-74","journal-title":"Ann Hematol"},{"issue":"Suppl 2","key":"7194_CR50","doi-asserted-by":"publisher","first-page":"S175","DOI":"10.1007\/s00277-003-0772-4","volume":"82","author":"H Einsele","year":"2003","unstructured":"Einsele H, Bertz H, Beyer J, Kiehl MG, Runde V, Kolb HJ et al (2003) Infectious complications after allogeneic stem cell transplantation: epidemiology and interventional therapy strategies\u2013guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 82(Suppl 2):S175\u2013S185","journal-title":"Ann Hematol"},{"issue":"Suppl 2","key":"7194_CR51","doi-asserted-by":"publisher","first-page":"S186","DOI":"10.1007\/s00277-003-0773-3","volume":"82","author":"OA Cornely","year":"2003","unstructured":"Cornely OA, B\u00f6hme A, Buchheidt D, Glasmacher A, Kahl C, Karthaus M et al (2003) Prophylaxis of invasive fungal infections in patients with hematological malignancies and solid tumors\u2013guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 82(Suppl 2):S186\u2013200","journal-title":"Ann Hematol"},{"issue":"50","key":"7194_CR52","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1055\/s-2001-18975","volume":"126","author":"A B\u00f6hme","year":"2001","unstructured":"B\u00f6hme A, Ruhnke M, Karthaus M, Einsele H, Guth S, Heussel G et al (2001) [Treatment of fungal infections in hematology and oncology. Guidelines of the Working Party on Infections in Hematology and Oncology (AGIHO) of the German Society for Hematology and Oncology (DGHO)]. Dtsch Med Wochenschr 126(50):1440\u20131447","journal-title":"Dtsch Med Wochenschr"},{"issue":"4","key":"7194_CR53","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1056\/NEJMoa061094","volume":"356","author":"OA Cornely","year":"2007","unstructured":"Cornely OA, Maertens J, Winston DJ, Perfect J, Ullmann AJ, Walsh TJ et al (2007) Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med 356(4):348\u2013359","journal-title":"N Engl J Med"},{"key":"7194_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2023.101190","volume":"92","author":"R Sprute","year":"2023","unstructured":"Sprute R, Nacov JA, Neofytos D, Oliverio M, Prattes J, Reinhold I et al (2023) Antifungal prophylaxis and pre-emptive therapy: when and how? Mol Aspects Med 92:101190","journal-title":"Mol Aspects Med"},{"issue":"5","key":"7194_CR55","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1001\/jamainternmed.2020.0403","volume":"180","author":"JA Trubiano","year":"2020","unstructured":"Trubiano JA, Vogrin S, Chua KYL, Bourke J, Yun J, Douglas A et al (2020) Development and Validation of a Penicillin Allergy Clinical Decision Rule. JAMA Intern Med 180(5):745\u2013752","journal-title":"JAMA Intern Med"},{"key":"7194_CR56","unstructured":"Stemler J, Sandherr M, Busch E, Cornely O AGIHO - Behandlungsstandard - Febrile Neutropenie [Available from: https:\/\/repository.publisso.de\/resource\/frl%3A6524890"},{"key":"7194_CR57","unstructured":"[Available from: https:\/\/clinicaltrials.gov\/study\/NCT04368559 ]"},{"issue":"6","key":"7194_CR58","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.cmi.2026.03.001","volume":"32","author":"J Stemler","year":"2026","unstructured":"Stemler J, Sprute R, Koehler P, Cornely OA (2026) How to safely discontinue antifungal treatment in invasive pulmonary aspergillosis?-clinical considerations in haematology. Clin Microbiol Infect 32(6):936\u2013941","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"7194_CR59","doi-asserted-by":"publisher","first-page":"e573","DOI":"10.1016\/S2352-3026(22)00166-1","volume":"9","author":"A Douglas","year":"2022","unstructured":"Douglas A, Thursky K, Spelman T, Szer J, Bajel A, Harrison S et al (2022) [(18)F]FDG-PET-CT compared with CT for persistent or recurrent neutropenic fever in high-risk patients (PIPPIN): a multicentre, open-label, phase 3, randomised, controlled trial. Lancet Haematol 9(8):e573\u2013e84","journal-title":"Lancet Haematol"},{"issue":"6","key":"7194_CR60","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1016\/S1473-3099(20)30847-1","volume":"21","author":"P Koehler","year":"2021","unstructured":"Koehler P, Bassetti M, Chakrabarti A, Chen SCA, Colombo AL, Hoenigl M et al (2021) Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis 21(6):e149\u2013e62","journal-title":"Lancet Infect Dis"},{"issue":"Suppl 1","key":"7194_CR61","doi-asserted-by":"publisher","DOI":"10.1111\/tid.14157","volume":"25","author":"E Kampouri","year":"2023","unstructured":"Kampouri E, Little JS, Rejeski K, Manuel O, Hammond SP, Hill JA (2023) Infections after chimeric antigen receptor (CAR)-T-cell therapy for hematologic malignancies. Transpl Infect Dis 25(Suppl 1):e14157","journal-title":"Transpl Infect Dis"},{"issue":"6","key":"7194_CR62","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1182\/bloodadvances.2024015008","volume":"9","author":"T Richardson","year":"2025","unstructured":"Richardson T, Sch\u00fctte D, Kobbe G, Baermann BN, Holderried TAW, Schmitz F et al (2025) Characteristics of infections after BCMA-directed CAR T-cell therapy for multiple myeloma: a real-world analysis. Blood Adv 9(6):1370\u20135","journal-title":"Blood Adv"},{"issue":"3","key":"7194_CR63","doi-asserted-by":"publisher","first-page":"ofag099","DOI":"10.1093\/ofid\/ofag099","volume":"13","author":"J Salmanton-Garc\u00eda","year":"2026","unstructured":"Salmanton-Garc\u00eda J, Marchesi F, Mackenzie E, Heras-Fernando I, Falces-Romero I, Vena A et al (2026) Underrated, Unvaccinated, Untreated: A Multinational Registry Analysis of Human Metapneumovirus in Hematological Malignancy, Insights From EPICOVIDEHA\/EPIRESEHA Registry. Open Forum Infect Dis 13(3):ofag099","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"7194_CR64","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/ajh.70166","volume":"101","author":"J Salmanton-Garc\u00eda","year":"2026","unstructured":"Salmanton-Garc\u00eda J, Marchesi F, Navr\u00e1til M, Falces-Romero I, Del Principe MI, Labrador J et al (2026) Beyond the usual suspects: RSV infection in patients with hematological malignancies compared to influenza and SARS-COV-2-A report from the EPICOVIDEHA\/EPIRESEHA Registry. Am J Hematol 101(2):365\u201375","journal-title":"Am J Hematol"},{"issue":"5","key":"7194_CR65","doi-asserted-by":"publisher","first-page":"e389","DOI":"10.1016\/S2352-3026(25)00049-3","volume":"12","author":"M Mikulska","year":"2025","unstructured":"Mikulska M, van B\u00f6mmel F, Mouliade C, Indolfi G, Kefalakes H, von Lilienfeld-Toal M et al (2025) Updated recommendations for the management of hepatitis B, C, and E virus infections in patients with haematological malignancies and those undergoing haematopoietic cell transplantation: recommendations from the 9th European Conference on Infections in Leukaemia (ECIL-9). Lancet Haematol 12(5):e389\u2013e99","journal-title":"Lancet Haematol"},{"issue":"7","key":"7194_CR66","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1038\/s41375-025-02586-7","volume":"39","author":"L Pagano","year":"2025","unstructured":"Pagano L, Maschmeyer G, Lamoth F, Blennow O, Xhaard A, Spadea M et al (2025) Primary antifungal prophylaxis in hematological malignancies. Updated clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL). Leukemia 39(7):1547\u201357","journal-title":"Leukemia"},{"issue":"4","key":"7194_CR67","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/s41375-019-0388-x","volume":"33","author":"G Maschmeyer","year":"2019","unstructured":"Maschmeyer G, De Greef J, Mellinghoff SC, Nosari A, Thiebaut-Bertrand A, Bergeron A et al (2019) Infections associated with immunotherapeutic and molecular targeted agents in hematology and oncology. A position paper by the European Conference on Infections in Leukemia (ECIL). Leukemia 33(4):844\u201362","journal-title":"Leukemia"},{"issue":"9","key":"7194_CR68","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1093\/jac\/dkw158","volume":"71","author":"G Maschmeyer","year":"2016","unstructured":"Maschmeyer G, Helweg-Larsen J, Pagano L, Robin C, Cordonnier C, Schellongowski P (2016) ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients. J Antimicrob Chemother 71(9):2405\u201313","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"7194_CR69","doi-asserted-by":"publisher","first-page":"e359","DOI":"10.1016\/S1473-3099(22)00227-4","volume":"22","author":"A Bergeron","year":"2022","unstructured":"Bergeron A, Mikulska M, De Greef J, Bondeelle L, Franquet T, Herrmann JL et al (2022) Mycobacterial infections in adults with haematological malignancies and haematopoietic stem cell transplants: guidelines from the 8th European Conference on Infections in Leukaemia. Lancet Infect Dis 22(12):e359\u2013e69","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"7194_CR70","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1038\/s41375-022-01556-7","volume":"36","author":"G Maschmeyer","year":"2022","unstructured":"Maschmeyer G, Bullinger L, Garcia-Vidal C, Herbrecht R, Maertens J, Menna P et al (2022) Infectious complications of targeted drugs and biotherapies in acute leukemia. Clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN). Leukemia 36(5):1215\u201326","journal-title":"Leukemia"},{"issue":"6","key":"7194_CR71","doi-asserted-by":"publisher","first-page":"e188","DOI":"10.1016\/S1473-3099(18)30601-7","volume":"19","author":"M Mikulska","year":"2017","unstructured":"Mikulska M, Cesaro S, de Lavallade H, Di Blasi R, Einarsdottir S, Gallo G et al (2017) Vaccination of patients with haematological malignancies who did not have transplantations: guidelines from the 2017 European Conference on Infections in Leukaemia (ECIL 7). Lancet Infect Dis 19(6):e188\u2013e99","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"7194_CR72","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1038\/sj.bmt.1704505","volume":"33","author":"P Ljungman","year":"2004","unstructured":"Ljungman P, Reusser P, de la Camara R, Einsele H, Engelhard D, Ribaud P et al (2004) Management of CMV infections: recommendations from the infectious diseases working party of the EBMT. Bone Marrow Transplant 33(11):1075\u201381","journal-title":"Bone Marrow Transplant"},{"key":"7194_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102393","volume":"67","author":"O Penack","year":"2024","unstructured":"Penack O, Tridello G, Salmenniemi U, Martino R, Khanna N, Perruccio K et al (2024) Influence of invasive aspergillosis during acute leukaemia treatment on survival after allogeneic stem cell transplantation: a prospective study of the EBMT Infectious Diseases Working Party. EClinicalMedicine 67:102393","journal-title":"EClinicalMedicine"},{"key":"7194_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2026.103792","volume":"93","author":"M Schmidt-Hieber","year":"2026","unstructured":"Schmidt-Hieber M, Ljungman P, Gilbert P, Knelange N, Drozd-Sokolowska J, Basak G et al (2026) Central nervous system disorders following haematopoietic stem cell transplantation: a prospective case-control observational study from the Infectious Diseases Working Party and the Transplant Complications Working Party of EBMT. EClinicalMedicine 93:103792","journal-title":"EClinicalMedicine"},{"issue":"5","key":"7194_CR75","doi-asserted-by":"publisher","first-page":"e280","DOI":"10.1016\/S1473-3099(24)00749-7","volume":"25","author":"OA Cornely","year":"2025","unstructured":"Cornely OA, Sprute R, Bassetti M, Chen SC, Groll AH, Kurzai O et al (2025) Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM. Lancet Infect Dis 25(5):e280\u2013e93","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"7194_CR76","doi-asserted-by":"publisher","first-page":"e495","DOI":"10.1016\/S1473-3099(23)00731-4","volume":"24","author":"CC Chang","year":"2024","unstructured":"Chang CC, Harrison TS, Bicanic TA, Chayakulkeeree M, Sorrell TC, Warris A et al (2024) Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM. Lancet Infect Dis 24(8):e495\u2013e512","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"7194_CR77","doi-asserted-by":"publisher","first-page":"e375","DOI":"10.1016\/S1473-3099(21)00203-6","volume":"21","author":"SC Chen","year":"2021","unstructured":"Chen SC, Perfect J, Colombo AL, Cornely OA, Groll AH, Seidel D et al (2021) Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM. Lancet Infect Dis 21(12):e375\u2013e86","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"7194_CR78","doi-asserted-by":"publisher","first-page":"e364","DOI":"10.1016\/S1473-3099(21)00191-2","volume":"21","author":"GR Thompson","year":"2021","unstructured":"Thompson GR 3rd, Le T, Chindamporn A, Kauffman CA, Alastruey-Izquierdo A, Ampel NM et al (2021) Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology. Lancet Infect Dis 21(12):e364\u2013e74","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"7194_CR79","doi-asserted-by":"publisher","first-page":"e246","DOI":"10.1016\/S1473-3099(20)30784-2","volume":"21","author":"M Hoenigl","year":"2021","unstructured":"Hoenigl M, Salmanton-Garc\u00eda J, Walsh TJ, Nucci M, Neoh CF, Jenks JD et al (2021) Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology. Lancet Infect Dis 21(8):e246\u2013e57","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"7194_CR80","doi-asserted-by":"publisher","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","volume":"19","author":"OA Cornely","year":"2019","unstructured":"Cornely OA, Alastruey-Izquierdo A, Arenz D, Chen SCA, Dannaoui E, Hochhegger B et al (2019) Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect Dis 19(12):e405\u2013e21","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"7194_CR81","doi-asserted-by":"publisher","first-page":"e742","DOI":"10.1097\/HS9.0000000000000742","volume":"6","author":"J Stemler","year":"2022","unstructured":"Stemler J, Cornely OA (2022) Antifungal Prophylaxis in Acute Myeloid Leukemia: New Drugs, New Challenges? Summary of the EHA Guideline on Antifungal Prophylaxis in Adult Patients With Acute Myeloid Leukemia Treated With Novel-targeted Therapies. Hemasphere 6(7):e742","journal-title":"Hemasphere"},{"issue":"5","key":"7194_CR82","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/s41409-025-02545-x","volume":"60","author":"E Gavriilaki","year":"2025","unstructured":"Gavriilaki E, Evangelidis P, Kotsiou N, Sakellari I, Cornely OA, Pagano L et al (2025) Antifungal prescription and stewardship in hematology and hematopoietic stem cell transplantation units worldwide: an international survey of EHA-SWG Infections in Hematology. Bone Marrow Transpl 60(5):729\u2013732","journal-title":"Bone Marrow Transpl"},{"issue":"5","key":"7194_CR83","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1007\/s15010-025-02598-6","volume":"53","author":"A Holzem","year":"2024","unstructured":"Holzem A, Stemler J, B\u00f6hm S, Gruell H, Zeuzem A, Schalk E et al (2024) Diverse clinical manifestations of Parvovirus B19 infections during the 2024 outbreak in Germany. Infection 53(5):2219\u201326","journal-title":"Infection"},{"issue":"3","key":"7194_CR84","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s10096-016-2833-3","volume":"36","author":"B Hermann","year":"2017","unstructured":"Hermann B, Lehners N, Brodhun M, Boden K, Hochhaus A, Kochanek M et al (2017) Influenza virus infections in patients with malignancies -- characteristics and outcome of the season 2014\/15. A survey conducted by the Infectious Diseases Working Party (AGIHO) of the German Society of Haematology and Medical Oncology (DGHO). Eur J Clin Microbiol Infect Dis 36(3):565\u2013573","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"9","key":"7194_CR85","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1093\/annonc\/mdp034","volume":"20","author":"G Maschmeyer","year":"2009","unstructured":"Maschmeyer G, Neuburger S, Fritz L, B\u00f6hme A, Penack O, Schwerdtfeger R et al (2009) A prospective, randomised study on the use of well-fitting masks for prevention of invasive aspergillosis in high-risk patients. Ann Oncol 20(9):1560\u20134","journal-title":"Ann Oncol"},{"issue":"6","key":"7194_CR86","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1111\/ejh.14098","volume":"111","author":"D Teschner","year":"2023","unstructured":"Teschner D, Berisha M, Panse J, Schmitt T, Fiegle E, Naendrup JH et al (2023) Chlorhexidine gluconate-coated gel pad dressings for prevention of central venous catheter-related bloodstream infections in patients with hematologic diseases or autologous stem cell transplantation: A registry-based matched-pair analysis. Eur J Haematol 111(6):914\u2013921","journal-title":"Eur J Haematol"},{"issue":"1\u20132","key":"7194_CR87","first-page":"37","volume":"48","author":"E Schalk","year":"2025","unstructured":"Schalk E, Seltmann A, B\u00f6ll B, Giesen N, Grans-Siebel J, Kriege O et al (2025) Sex-disaggregated analysis of central venous catheter-related bloodstream infections in patients with cancer. Oncol Res Treat 48(1\u20132):37\u201347","journal-title":"Oncol Res Treat"},{"issue":"1","key":"7194_CR88","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13756-025-01674-8","volume":"14","author":"M Schmidt-Hieber","year":"2025","unstructured":"Schmidt-Hieber M, Kriege O, Panse J, Naendrup JH, B\u00f6ll B, Hentrich M et al (2025) Incidence of central venous catheter-related bloodstream infections before, during, and after the SARS-CoV-2 pandemic: a registry-based cohort study. Antimicrob Resist Infect Control 14(1):149","journal-title":"Antimicrob Resist Infect Control"},{"issue":"10","key":"7194_CR89","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1007\/s00277-022-04958-w","volume":"101","author":"J Panse","year":"2022","unstructured":"Panse J, T\u00f6lle D, Fiegle E, Naendrup JH, Schmidt-Hieber M, B\u00f6ll B et al (2022) Scheduled removal of central venous catheters (CVC) to prevent CVC-related bloodstream infections in patients with hematological disease or autologous stem cell transplantation: a registry-based randomized simulation-study. Ann Hematol 101(10):2317\u20132324","journal-title":"Ann Hematol"},{"key":"7194_CR90","unstructured":"ClinicalTrials.gov (2023) FungiScope - A Global Emerging Fungal Infection Registry (FungiScope) (NCT01731353). Retrieved on 19 March from https:\/\/clinicaltrials.gov\/study\/NCT01731353"},{"issue":"6","key":"7194_CR91","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1093\/jac\/dkab039","volume":"76","author":"R Sprute","year":"2021","unstructured":"Sprute R, Salmanton-Garc\u00eda J, Sal E, Malaj X, R\u00e1\u010dil Z, Ruiz de Alegr\u00eda Puig C et al (2021) Invasive infections with Purpureocillium lilacinum: clinical characteristics and outcome of 101 cases from FungiScope\u00ae and the literature. J Antimicrob Chemother 76(6):1593\u2013603","journal-title":"J Antimicrob Chemother"},{"key":"7194_CR92","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ijid.2019.12.017","volume":"92","author":"D Seidel","year":"2020","unstructured":"Seidel D, Hassler A, Salmanton-Garc\u00eda J, Koehler P, Mellinghoff SC, Carlesse F et al (2020) Invasive Scedosporium spp. and Lomentospora prolificans infections in pediatric patients: analysis of 55 cases from FungiScope\u00ae and the literature. Int J Infect Dis 92:114\u201322","journal-title":"Int J Infect Dis"},{"issue":"1","key":"7194_CR93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/1040841X.2018.1514366","volume":"45","author":"D Seidel","year":"2019","unstructured":"Seidel D, Mei\u00dfner A, Lackner M, Piepenbrock E, Salmanton-Garc\u00eda J, Stecher M et al (2019) Prognostic factors in 264 adults with invasive Scedosporium spp. and Lomentospora prolificans infection reported in the literature and FungiScope(\u00ae). Crit Rev Microbiol 45(1):1\u201321","journal-title":"Crit Rev Microbiol"},{"issue":"3","key":"7194_CR94","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/myc.13039","volume":"63","author":"J Stemler","year":"2020","unstructured":"Stemler J, Salmanton-Garc\u00eda J, Seidel D, Alexander BD, Bertz H, Hoenigl M et al (2020) Risk factors and mortality in invasive Rasamsonia spp. infection: Analysis of cases in the FungiScope(\u00ae) registry and from the literature. Mycoses 63(3):265\u2013274","journal-title":"Mycoses"},{"issue":"3","key":"7194_CR95","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1093\/jac\/dkaa481","volume":"76","author":"R Sprute","year":"2021","unstructured":"Sprute R, Salmanton-Garc\u00eda J, Sal E, Malaj X, Falces-Romero I, Hatvani L et al (2021) Characterization and outcome of invasive infections due to Paecilomyces variotii: analysis of patients from the FungiScope\u00ae registry and literature reports. J Antimicrob Chemother 76(3):765\u201374","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"7194_CR96","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/myc.13524","volume":"66","author":"MI Del Principe","year":"2023","unstructured":"Del Principe MI, Seidel D, Criscuolo M, Dargenio M, R\u00e1cil Z, Piedimonte M et al (2023) Clinical features and prognostic factors of Magnusiomyces (Saprochaete) infections in haematology. A multicentre study of SEIFEM\/Fungiscope. Mycoses 66(1):35\u201346","journal-title":"Mycoses"},{"issue":"9","key":"7194_CR97","doi-asserted-by":"publisher","DOI":"10.1111\/myc.70114","volume":"68","author":"I Reinhold","year":"2025","unstructured":"Reinhold I, Mori G, Lanzafame M, Limongelli A, Vena A, G\u00f6tz J et al (2025) Rezafungin utilisation in real life-FungiScope results from Europe and the United States. Mycoses 68(9):e70114","journal-title":"Mycoses"},{"issue":"5","key":"7194_CR98","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/myc.13067","volume":"63","author":"JD Jenks","year":"2020","unstructured":"Jenks JD, Seidel D, Cornely OA, Chen S, van Hal S, Kauffman C et al (2020) Clinical characteristics and outcomes of invasive Lomentospora prolificans infections: Analysis of patients in the FungiScope(\u00ae) registry. Mycoses 63(5):437\u2013442","journal-title":"Mycoses"},{"issue":"6","key":"7194_CR99","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/S1473-3099(22)00872-6","volume":"23","author":"M Hoenigl","year":"2023","unstructured":"Hoenigl M, Salmanton-Garc\u00eda J, Egger M, Gangneux JP, Bicanic T, Arikan-Akdagli S et al (2023) Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study. Lancet Infect Dis 23(6):751\u201361","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"7194_CR100","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.cmi.2023.03.008","volume":"29","author":"L \u00d6zbek","year":"2023","unstructured":"\u00d6zbek L, Top\u00e7u U, Manay M, Esen BH, Bektas SN, Ayd\u0131n S et al (2023) COVID-19-associated mucormycosis: a systematic review and meta-analysis of 958 cases. Clin Microbiol Infect 29(6):722\u2013731","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"7194_CR101","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/S1473-3099(16)00071-2","volume":"16","author":"FM Marty","year":"2016","unstructured":"Marty FM, Ostrosky-Zeichner L, Cornely OA, Mullane KM, Perfect JR, Thompson GR 3 et al (2016) Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis. Lancet Infect Dis 16(7):828\u2013837","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"7194_CR102","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000612","volume":"5","author":"J Salmanton-Garc\u00eda","year":"2021","unstructured":"Salmanton-Garc\u00eda J, Busca A, Cornely OA, Corradini P, Hoenigl M, Klimko N et al (2021) EPICOVIDEHA: a ready to use platform for epidemiological studies in hematological patients with COVID-19. Hemasphere 5(7):e612","journal-title":"Hemasphere"},{"issue":"11","key":"7194_CR103","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000970","volume":"7","author":"J Salmanton-Garc\u00eda","year":"2023","unstructured":"Salmanton-Garc\u00eda J, Marchesi F, Itri F, Farina F, Hoenigl M, C\u00f3rdoba R et al (2023) Unveiling the hidden burden: from EPICOVIDEHA to EPIFLUEHA, exploring the epidemiology of respiratory viral infections in hematological patients. Hemasphere 7(11):e970","journal-title":"Hemasphere"},{"issue":"3","key":"7194_CR104","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/ajh.27565","volume":"100","author":"J Salmanton-Garc\u00eda","year":"2025","unstructured":"Salmanton-Garc\u00eda J, Marchesi F, Navr\u00e1til M, Piukovics K, Del Principe MI, Criscuolo M et al (2025) Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn\/Winter 2023\u20132024: EPICOVIDEHA-EPIFLUEHA Report. Am J Hematol 100(3):358\u2013374","journal-title":"Am J Hematol"},{"issue":"8","key":"7194_CR105","first-page":"2693","volume":"109","author":"TF Aiello","year":"2024","unstructured":"Aiello TF, Salmanton-Garcia J, Marchesi F, Weinbergerova B, Glenthoj A, Van Praet J et al (2024) Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA registry. Haematologica 109(8):2693\u2013700","journal-title":"Haematologica"},{"issue":"3","key":"7194_CR106","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s15010-023-02169-7","volume":"52","author":"T Lahmer","year":"2024","unstructured":"Lahmer T, Salmanton-Garc\u00eda J, Marchesi F, El-Ashwah S, Nucci M, Besson C et al (2024) Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey. Infection 52(3):1125\u201341","journal-title":"Infection"},{"key":"7194_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102553","volume":"71","author":"J Salmanton-Garc\u00eda","year":"2020","unstructured":"Salmanton-Garc\u00eda J, Marchesi F, Farina F, Weinbergerov\u00e1 B, Itri F, D\u00e1vila-Valls J et al (2020) Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022. EClinicalMedicine 71:102553","journal-title":"EClinicalMedicine"},{"issue":"2","key":"7194_CR108","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1080\/10428194.2023.2280886","volume":"65","author":"S El-Ashwah","year":"2024","unstructured":"El-Ashwah S, Salmanton-Garc\u00eda J, Bilgin YM, Itri F, \u017d\u00e1k P, Weinbergerov\u00e1 B et al (2024) The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey. Leuk Lymphoma 65(2):199\u2013208","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"7194_CR109","doi-asserted-by":"publisher","DOI":"10.1002\/hon.3240","volume":"42","author":"P Musto","year":"2024","unstructured":"Musto P, Salmanton-Garc\u00eda J, Sgherza N, Bergantim R, Farina F, Glenth\u00f8j A et al (2024) Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: results from the EPICOVIDEHA registry. Hematol Oncol 42(1):e3240","journal-title":"Hematol Oncol"},{"key":"7194_CR110","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ijid.2023.10.013","volume":"137","author":"G Rossi","year":"2023","unstructured":"Rossi G, Salmanton-Garc\u00eda J, Cattaneo C, Marchesi F, D\u00e1vila-Valls J, Mart\u00edn-P\u00e9rez S et al (2023) Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings. Int J Infect Dis 137:98\u2013110","journal-title":"Int J Infect Dis"},{"issue":"4","key":"7194_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.106952","volume":"62","author":"J Salmanton-Garc\u00eda","year":"2023","unstructured":"Salmanton-Garc\u00eda J, Marchesi F, Koehler P, Weinbergerov\u00e1 B, \u010colovi\u0107 N, Falces-Romero I et al (2023) Molnupiravir compared to nirmatrelvir\/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry. Int J Antimicrob Agents 62(4):106952","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"7194_CR112","doi-asserted-by":"publisher","first-page":"225","DOI":"10.18176\/jiaci.0845","volume":"33","author":"M Criscuolo","year":"2023","unstructured":"Criscuolo M, Salmanton-Garc\u00eda J, Fracchiolla N, Dragonetti G, Khanna N, Weinbergerov\u00e1 B et al (2023) SARS-CoV-2 Infection In Patients With Mastocytosis: An EPICOVIDEHA Report. J Investig Allergol Clin Immunol 33(3):225\u2013227","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"11","key":"7194_CR113","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1182\/bloodadvances.2022009578","volume":"7","author":"JA van Doesum","year":"2023","unstructured":"van Doesum JA, Salmanton-Garc\u00eda J, Marchesi F, Di Blasi R, Falces-Romero I, Cabirta A et al (2023) Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post\u2013CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey. Blood Adv 7(11):2645\u201355","journal-title":"Blood Adv"},{"key":"7194_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.101939","volume":"58","author":"J Salmanton-Garc\u00eda","year":"2023","unstructured":"Salmanton-Garc\u00eda J, Marchesi F, Gomes da Silva M, Farina F, D\u00e1vila-Valls J, Bilgin YM et al (2023) Nirmatrelvir\/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry. eClinicalMedicine 58:101939","journal-title":"eClinicalMedicine"},{"issue":"1","key":"7194_CR115","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13045-023-01423-7","volume":"16","author":"F Marchesi","year":"2023","unstructured":"Marchesi F, Salmanton-Garc\u00eda J, Buquicchio C, Itri F, Besson C, D\u00e1vila-Valls J et al (2023) Passive pre-exposure immunization by tixagevimab\/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry. J Hematol Oncol 16(1):32","journal-title":"J Hematol Oncol"},{"key":"7194_CR116","doi-asserted-by":"publisher","DOI":"10.1177\/20406207231154706","volume":"14","author":"M Marchetti","year":"2023","unstructured":"Marchetti M, Salmanton-Garc\u00eda J, El-Ashwah S, Verga L, Itri F, R\u00e1\u010dil Z et al (2023) Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry. Ther Adv Hematol 14:20406207231154706","journal-title":"Ther Adv Hematol"},{"key":"7194_CR117","doi-asserted-by":"crossref","unstructured":"Busca A, Salmanton-Garc\u00eda J, Marchesi F, Farina F, Seval GC, Van Doesum J et al (2023) Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry. Front Immunol. ;Volume 14\u20132023","DOI":"10.3389\/fimmu.2023.1125030"},{"issue":"26","key":"7194_CR118","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1182\/blood.2022017257","volume":"140","author":"L Pagano","year":"2022","unstructured":"Pagano L, Salmanton-Garc\u00eda J, Marchesi F, Blennow O, Gomes da Silva M, Glenth\u00f8j A et al (2022) Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey. Blood 140(26):2773\u201387","journal-title":"Blood"},{"key":"7194_CR119","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14225530","author":"C Cattaneo","year":"2022","unstructured":"Cattaneo C, Salmanton-Garc\u00eda J, Marchesi F, El-Ashwah S, Itri F, Weinbergerov\u00e1 B et al (2022) Simultaneous onset of haematological malignancy and COVID: an Epicovideha survey. Cancers (Basel) 5530. https:\/\/doi.org\/10.3390\/cancers14225530","journal-title":"Cancers (Basel)"},{"issue":"11","key":"7194_CR120","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000789","volume":"6","author":"J Salmanton-Garc\u00eda","year":"2022","unstructured":"Salmanton-Garc\u00eda J, Marchesi F, Glenth\u00f8j A, Bilgin YM, van Praet J, D\u00e1vila-Valls J et al (2022) Improved clinical outcome of COVID-19 in hematologic malignancy patients receiving a fourth dose of anti-SARS-CoV-2 vaccine: an EPICOVIDEHA report. HemaSphere 6(11):e789","journal-title":"HemaSphere"},{"key":"7194_CR121","doi-asserted-by":"crossref","unstructured":"Infante MS, Salmanton-Garc\u00eda J, Fern\u00e1ndez-Cruz A, Marchesi F, Jaksic O, Weinbergerov\u00e1 B et al (2022) B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA). Front Oncol. ;Volume 12\u20132022","DOI":"10.1097\/01.HS9.0000844012.13018.0a"},{"issue":"8","key":"7194_CR122","doi-asserted-by":"publisher","first-page":"E312","DOI":"10.1002\/ajh.26626","volume":"97","author":"O Blennow","year":"2022","unstructured":"Blennow O, Salmanton-Garc\u00eda J, Nowak P, Itri F, Van Doesum J, L\u00f3pez-Garc\u00eda A et al (2022) Outcome of infection with omicron SARS-CoV-2 variant in patients with hematological malignancies: an EPICOVIDEHA survey report. Am J Hematol 97(8):E312\u2013E7","journal-title":"Am J Hematol"},{"issue":"13","key":"7194_CR123","doi-asserted-by":"publisher","first-page":"3870","DOI":"10.1182\/bloodadvances.2022007357","volume":"6","author":"S Lamure","year":"2022","unstructured":"Lamure S, Salmanton-Garc\u00eda J, Robin-Marieton E, Jaksic O, Kohn M, Marchesi F et al (2022) COVID-19 and hairy-cell leukemia: an EPICOVIDEHA survey. Blood Adv 6(13):3870\u20134","journal-title":"Blood Adv"},{"issue":"7","key":"7194_CR124","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1182\/bloodadvances.2021005616","volume":"6","author":"A Busca","year":"2022","unstructured":"Busca A, Salmanton-Garc\u00eda J, Corradini P, Marchesi F, Cabirta A, Di Blasi R et al (2022) COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP. Blood Adv 6(7):2427\u201333","journal-title":"Blood Adv"},{"issue":"10","key":"7194_CR125","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1182\/blood.2021014124","volume":"139","author":"L Pagano","year":"2022","unstructured":"Pagano L, Salmanton-Garc\u00eda J, Marchesi F, L\u00f3pez-Garc\u00eda A, Lamure S, Itri F et al (2022) COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA. Blood 139(10):1588\u201392","journal-title":"Blood"},{"issue":"1","key":"7194_CR126","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s13045-021-01177-0","volume":"14","author":"L Pagano","year":"2021","unstructured":"Pagano L, Salmanton-Garc\u00eda J, Marchesi F, Busca A, Corradini P, Hoenigl M et al (2021) COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA). J Hematol Oncol 14(1):168","journal-title":"J Hematol Oncol"},{"key":"7194_CR127","unstructured":"Specialized Working Group on Infections in Hematology - Continuation of EPICOVIDEHA Survey Retrieved on March 18, 2026 [Available from: https:\/\/ehaweb.org\/research-innovation\/specialized-working-groups\/specialized-working-group-on-infections-in-hematology\/highlights-2"},{"key":"7194_CR128","unstructured":"Molecular pathogen diagnostics and studies of SARS-CoV-2 in patients with CNS disorder after hematopoietic stem cell transplantation and healthy subjects ((ZNMoDiSZ) (DRKS00029343). Retrieved on 19 (2026) March from https:\/\/drks.de\/search\/en\/trial\/DRKS00029343\/details"},{"issue":"24","key":"7194_CR129","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1056\/NEJMoa1803396","volume":"380","author":"MR Wilson","year":"2019","unstructured":"Wilson MR, Sample HA, Zorn KC, Arevalo S, Yu G, Neuhaus J et al (2019) Clinical Metagenomic Sequencing for Diagnosis of Meningitis and Encephalitis. N Engl J Med 380(24):2327\u20132340","journal-title":"N Engl J Med"},{"issue":"11","key":"7194_CR130","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00277-008-0509-5","volume":"87","author":"HH Wolf","year":"2008","unstructured":"Wolf HH, Leith\u00e4user M, Maschmeyer G, Salwender H, Klein U, Chaberny I et al (2008) Central venous catheter-related infections in hematology and oncology: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 87(11):863\u2013876","journal-title":"Ann Hematol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-07194-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07194-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07194-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T10:02:19Z","timestamp":1786788139000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-026-07194-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":130,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["7194"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-07194-8","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,3]]},"assertion":[{"value":"2 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors declare that they have no conflicts of interest in relation to this manuscript.","order":1,"name":"Ethics","label":"Conflict of interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"357"}}